Inhibition of HBV Replication by Delivering the Dual-gene Expression Vector pHsa-miR16-siRNA in HepG2.2.15 Cells  

Inhibition of HBV Replication by Delivering the Dual-gene Expression Vector pHsa-miR16-siRNA in HepG2.2.15 Cells

在线阅读下载全文

作  者:魏巍 汪速飞 余冰 倪明 

机构地区:[1]Department of Pathogen Biology,School of Basic Medicine,Tongji Medical College,Huazhong University of Science and Technology [2]Department of Infectious Disease,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology

出  处:《Journal of Huazhong University of Science and Technology(Medical Sciences)》2017年第6期828-832,共5页华中科技大学学报(医学英德文版)

基  金:supported by grants from the Independent Innovation Research Fund of Huazhong University of Science and Technology(No.2016YXMS200);Natural Science Foundation of the Science and Technology Department of Hubei Province(No.ZRMS2017000406)

摘  要:This study aimed to construct the dual-gene expression vector p Hsa-miR16-siRNA which can express human miR-16 and HBV X siRNA, and examine its regulatory effect on HBV gene expression in the HepG2.2.15 cell line. The expression vectors siR-1583 and pHsa-miR16-siRNA were designed and constructed. Hep G2.2.15 cells were transfected with the empty vector, siR-1583, pmiR-16 and pHsa-miR16-siRNA, respectively. ELISA was performed to measure the expression of HBsAg and HBeAg in the culture supernatant 48 and72 h post transfection. Fluorescence quantitative PCR was used to measure the HBV mRNA degradation efficiency and HBV DNA copy number. The results showed that the expression of HBV genes was significantly inhibited in Hep G2.2.15 cells transfected with siR-1583, pmiR-16 and pHsa-miR16-siRNA, respectively, when compared with that in cells transfected with the empty vectors, with the inhibitory effect of pHsa-miR16-siRNA being the most significant. ELISA showed that the inhibitory rates of HBs Ag and HBeAg in pHsa-miR16-siRNA transfected cells were correspondingly 87.3% and 85.0% at 48 h, and 88.6% and 86.5% at 72 h post transfection(P〈0.01 vs. control group). RT-PCR showed that the level of HBV mRNA decreased by 80.2%(t=–99.22, P〈0.01), the genomic HBV DNA by 92.8%(t=–73.06, P〈0.01), and the supernatant of HBV DNA copy number by 89.8%(t=–47.13, P〈0.01) in pHsa-miR16-siRNA transfected group. It was suggested that the dual-gene expression vector pHsa-miR16-siRNA can inhibit the replication of HBV more efficiently than a single-gene expression vector.This study aimed to construct the dual-gene expression vector p Hsa-miR16-siRNA which can express human miR-16 and HBV X siRNA, and examine its regulatory effect on HBV gene expression in the HepG2.2.15 cell line. The expression vectors siR-1583 and pHsa-miR16-siRNA were designed and constructed. Hep G2.2.15 cells were transfected with the empty vector, siR-1583, pmiR-16 and pHsa-miR16-siRNA, respectively. ELISA was performed to measure the expression of HBsAg and HBeAg in the culture supernatant 48 and72 h post transfection. Fluorescence quantitative PCR was used to measure the HBV mRNA degradation efficiency and HBV DNA copy number. The results showed that the expression of HBV genes was significantly inhibited in Hep G2.2.15 cells transfected with siR-1583, pmiR-16 and pHsa-miR16-siRNA, respectively, when compared with that in cells transfected with the empty vectors, with the inhibitory effect of pHsa-miR16-siRNA being the most significant. ELISA showed that the inhibitory rates of HBs Ag and HBeAg in pHsa-miR16-siRNA transfected cells were correspondingly 87.3% and 85.0% at 48 h, and 88.6% and 86.5% at 72 h post transfection(P〈0.01 vs. control group). RT-PCR showed that the level of HBV mRNA decreased by 80.2%(t=–99.22, P〈0.01), the genomic HBV DNA by 92.8%(t=–73.06, P〈0.01), and the supernatant of HBV DNA copy number by 89.8%(t=–47.13, P〈0.01) in pHsa-miR16-siRNA transfected group. It was suggested that the dual-gene expression vector pHsa-miR16-siRNA can inhibit the replication of HBV more efficiently than a single-gene expression vector.

关 键 词:dual expression vector HBV DNA HBV mRNA gene expression 

分 类 号:R512.62[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象